On August 05, 2026, Core Scientific Inc CORZ shares fell 4.6% to $21.77, continuing the volatility seen over the past year. The stock has traded between $13.14 and $30.46 over the last 52 weeks, reflecting a significant range of investor sentiment.
- GF Valueâ„¢ verdict indicates that CORZ is currently priced at $21.77, which is 101.4% above its estimated fair value of $10.81.
- With a GF Scoreâ„¢ of 40/100, CORZ is categorized as average, suggesting mixed signals about its overall investment quality.
- The most notable signal is the insider activity, where insiders have sold $3.0 million worth of shares in the last three months, with no buying observed.
Is CORZ Overvalued or Undervalued?
Core Scientific Inc CORZ is currently trading significantly above its GF Valueâ„¢, which is GuruFocus' proprietary estimate of intrinsic value based on historical trading multiples, past growth, and future performance potential. With a current price of $21.77 and a GF Valueâ„¢ of $10.81, the stock is deemed significantly overvalued, presenting a margin of safety risk for prospective investors. This overvaluation is further reinforced by the GF Valuation label, which categorizes CORZ as significantly overvalued.
Given that CORZ has not yet achieved profitability or positive cash flow, using traditional earnings-based metrics like the Price-to-Earnings (P/E) ratio may not be applicable. Instead, a Price-to-Sales (P/S) analysis is more relevant, especially when considering the company's historical median P/S ratio of approximately 7.3x. The current valuation reflects a disconnect between market sentiment and the underlying financial realities of Core Scientific, suggesting heightened risk for current shareholders.
How Does CORZ's Valuation Compare to Its History?
| Metric | Current | Historical |
|---|---|---|
| P/E (TTM) | N/A (loss-making) | 26.4x (5-Year Median) |
| Forward P/E | 1028.4x | N/A |
Due to the lack of a meaningful trailing P/E ratio, analysis based on this metric is not applicable. However, the exceptionally high forward P/E of 1028.4x starkly contrasts with the historical median of 26.4x, indicating that the stock is trading at an extremely elevated valuation compared to its historical norms. This analysis aligns with the GF Valueâ„¢ verdict, reinforcing the conclusion that CORZ is significantly overvalued at its current price point.
What Does CORZ's GF Scoreâ„¢ Tell Us?
The GF Scoreâ„¢ is a comprehensive measure that evaluates a stock's financial strength, profitability, growth prospects, valuation, and momentum. For Core Scientific, the GF Scoreâ„¢ of 40/100 indicates that while the company possesses some average characteristics, there are significant weaknesses to address. The strongest sub-rank is the growth rank at 9/10, reflecting potential future growth, while the weakest sub-rank is the valuation rank at 1/10, indicating overvaluation concerns.
| Metric | Rating |
|---|---|
| GF Scoreâ„¢ | 40/100 |
| Financial Strength | 2/10 |
| Profitability | 4/10 |
| Growth | 9/10 |
| Valuation | 1/10 |
| Momentum | 0/10 |
These scores illustrate that while Core Scientific has robust growth potential, its financial strength and valuation rankings are concerning. The low financial strength score of 2/10 suggests significant risk factors, which, coupled with a poor momentum rank of 0/10, indicates that the stock may encounter further downward pressure in the near term.
What Are Gurus and Insiders Doing with CORZ?
Currently, eight gurus hold positions in Core Scientific, with an even split of four adding to their stakes and four trimming their positions in recent quarters. This mixed activity from institutional investors suggests indecision or varying outlooks on the company's future prospects.
In addition, the recent insider selling of $3.0 million without any buying activity raises red flags about the company's immediate outlook and management's confidence in its current valuation. Such a trend typically suggests insiders may believe the stock is overpriced or that they anticipate challenges ahead. This pattern of selling could be interpreted as a signal for caution among other investors considering entering or holding positions in CORZ.
What This Means for Investors
Given the significant overvaluation indicated by the GF Valueâ„¢ assessment and the concerning insider activity, it appears that Core Scientific Inc CORZ is currently overvalued. Investors should proceed with caution, particularly in light of the company's financial challenges and mixed signals from both insiders and institutional investors. For more detailed insights, visit the Core Scientific Inc (CORZ) stock page.
Frequently Asked Questions
What is CORZ's GF Scoreâ„¢?
The GF Scoreâ„¢ for Core Scientific is 40/100, indicating an average investment quality with some strengths and notable weaknesses.
Is CORZ overvalued or undervalued?
According to the GF Valueâ„¢, CORZ is significantly overvalued at its current price of $21.77, which is 101.4% above its estimated fair value.
What is CORZ's P/E ratio?
Core Scientific has a forward P/E ratio of 1028.4x, while its trailing P/E ratio is not applicable due to losses. This contrasts sharply with its historical median P/E of 26.4x, indicating significant overvaluation.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
